|

AG chemotherapy Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Zhejiang Cancer Hospital1
  • Tianjin Medical University Cancer Institute and Hospital1

Indications

  • Cancer2
  • Liver Disease1
  • Non-Resectable Pancreas Carcinoma1
  • Pancreatic Cancer1
  • Liver Cancer1

Other2 trials

Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
Phase 2
Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.